Skip to content

Acupuncture Treatment for Knee Osteoarthritis With Sensitive Acupoints and Tender Points

A Multi-center Randomized Controlled Trial of Acupuncture Treatment for Knee Osteoarthritis With Sensitive Acupoints and Tender Points

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03299439
Enrollment
666
Registered
2017-10-03
Start date
2017-10-25
Completion date
2020-11-20
Last updated
2021-12-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acupuncture, Knee Osteoarthritis, Sensitive Acupoints, Tender Points

Brief summary

The investigators plan to investigate the effectiveness of acupuncture at highly sensitive points, compared with lowly/non-sensitive points or no acupuncture (waiting-list), in improving pain, joint function and quality of life, among patients with KOA. The safety of acupuncture will also be assessed during the study period.

Detailed description

Participants in the high sensitization group receive acupuncture treatment at the five highly sensitive points; Participants in the low/non-sensitization group receive acupuncture treatment at the five low/non-sensitive points and all other treatment settings will be the same as in the high sensitization group. Patients in the waiting-list group will receive standard acupuncture treatment after the study is completed.

Interventions

OTHERacupuncture

a stimulation of the body or auricular points

Sponsors

West China Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participants aged 40 years or older and diagnosed with mild or moderate knee osteoarthritis(KOA) are eligible to participate in the study * The following criteria are used for diagnosis of KOA: * refractory knee pain for most days in the last month; * joint space narrowing, sclerosis or cystic change in subchondral bone (as demonstrated in X-ray); * laboratory examinations of arthritis: clear and viscous synovial fluid (≥2 times) and white blood cell count \< 2000/mm3; * morning stiffness continues less than 30 minutes; * bone sound exists when joints was taking flexion and/or extension. If a patient meets criteria 1 and 2, or criteria 1, 3, 4, and 5, a diagnosis of KOA is confirmed.

Exclusion criteria

Patients will be excluded if they meet any of the following: * diagnosed with conditions leading to skeletal disorders, such as tuberculosis, tumors or rheumatism of the knee joint and rheumatoid arthritis; * present sprain or trauma in the lower limb; * unable to walk properly due to foot deformity or pain; * present with mental disorders; * present with comorbidities including severe cardiovascular disease, liver or kidney impairment, immunodeficiency, diabetes mellitus, blood disorder or skin disease; * females who are pregnant or lactating; * using physiotherapy treatments for osteoarthritis knee pain; * have used intra-articular injection of glucocorticoid or viscosupplementation in the past six months; * received knee-replacement surgery; * diagnosed with severe (stage 4, according to Kellgren and Lawrence radiographic classification) or late clinical stage of KOA; * have a swollen knee or positive result of floating patella test; or' * are participating or have participated in the other clinical trials.

Design outcomes

Primary

MeasureTime frameDescription
The change of Western Ontario and McMaster Universities Osteoarthritis index total score from baseline to 16 weeksAssessments will be conducted at baseline and 16 weeks after randomizationIt consists of 24 items assessing the knee osteoarthritis patients pain, stiffness, and physical function. Each of the 24 items will be graded on a visual analog scale ranging from 0 to 10, with higher scores reflecting more pain, stiffness and poorer physical function.

Secondary

MeasureTime frameDescription
The change of Short Form (SF)-12 health survey score from baseline to 16 weeksAssessments will be conducted at baseline and 16 weeks after randomizationIt includes 12 items: 2 items on physical functioning, 2 items on role limitations because of physical health problems, 1 item on bodily pain, 1 item on general health perceptions, 1 item on vitality (energy/fatigue), 1 item on social functioning, 2 items on role limitations because of emotional problems, and 2 items on general mental health (psychological distress and psychological well-being).
The changes of knee ranges of motion (ROMs) from baseline to 16 weeksAssessments will be conducted at baseline and 16 weeks after randomizationThe knee ROMs will be assessed both actively and passively by using a standard goniometer. It will include flexion, extension, internal rotation and external rotation.
The changes of pressure-pain threshold of the five selected acupuncture points from baseline to 16 weeksAssessments will be conducted at baseline and 16 weeks after randomizationThe pressure-pain threshold of the five selected acupuncture points will be measured using the electronic von Frey detector.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026